JMF
APTO

Johnson Midwest Financial’s Aptose Biosciences, Inc. APTO Stock Holding History

Johnson Midwest Financial’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$423 Hold
5
– – ﹤0.01% 361
2023
Q2 		$701 Hold
5
– – ﹤0.01% 349
2023
Q1 		$1.46K Buy
+5
New +$1.45K ﹤0.01% 344

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Johnson Midwest Financial's APTO Position: Q3 2023 in Review

Johnson Midwest Financial held its Aptose Biosciences, Inc. (APTO) position steady in Q3 2023 at 5 shares worth $423. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Johnson Midwest Financial first reported a position in APTO in Q1 2023 and has held it in 3 quarters since. The position peaked at $1.46K in Q1 2023. 25 funds tracked by Wall St. Rank hold APTO as of Q3 2023.

  • Johnson Midwest Financial held 5 shares of Aptose Biosciences, Inc. worth $423 as of Q3 2023.
  • Johnson Midwest Financial left its Aptose Biosciences, Inc. share count unchanged in Q3 2023.
  • Aptose Biosciences, Inc. made up ﹤0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #361 holding.
  • Johnson Midwest Financial first reported a position in Aptose Biosciences, Inc. in Q1 2023 and has held it in 3 quarters since.
  • Johnson Midwest Financial's Aptose Biosciences, Inc. position peaked at $1.46K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.